Key statistics
As of last trade Belite Bio Inc (BLTE:NAQ) traded at 78.60, -9.16% below its 52-week high of 86.53, set on Nov 14, 2024.
52-week range
Open | 82.00 |
---|---|
High | 82.07 |
Low | 78.60 |
Bid | 77.95 |
Offer | 80.18 |
Previous close | 82.45 |
Average volume | 93.24k |
---|---|
Shares outstanding | 30.61m |
Free float | 29.23m |
P/E (TTM) | -- |
Market cap | 2.52bn USD |
EPS (TTM) | -1.11 USD |
Data delayed at least 15 minutes, as of Nov 22 2024 19:01 GMT.
More ▼
- Belite Bio Reports Third Quarter 2024 Financial Results and Provides a Corporate Update
- Belite Bio to Host Webcast on November 12, 2024, to Discuss Third Quarter 2024 Financial Results
- Belite Bio Announces Exercise of Warrants for US$28.75 Million Gross Proceeds
- Belite Bio Announces Presentations at the American Academy of Ophthalmology 2024 Annual Meeting
- Belite Bio to Participate in the Maxim Group 2024 Healthcare Virtual Summit
- Belite Bio Announces First Patient Dosed in Phase 2/3 DRAGON II Trial of Tinlarebant for the Treatment of Stargardt Disease
- Belite Bio to Participate in Three Upcoming Investor Conferences
- Belite Bio Announces Appointment of Hendrik P. N. Scholl, MD, MA, as Chief Medical Officer
- Belite Bio Reports Second Quarter 2024 Financial Results and Provides a Corporate Update
- Belite Bio to Present at the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference
More ▼